Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
siRNA therapeutics have promise for the treatment of a wide range of genetic disorders.
Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA …
Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA …
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Y Dong, KT Love, JR Dorkin… - … of the National …, 2014 - utsouthwestern.elsevierpure.com
Abstract siRNA therapeutics have promise for the treatment of a wide range of genetic
disorders. Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and …
disorders. Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and …
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates.
Y Dong, KT Love, JR Dorkin… - Proceedings of the …, 2014 - europepmc.org
siRNA therapeutics have promise for the treatment of a wide range of genetic disorders.
Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA …
Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA …
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Y Dong, KT Love, JR Dorkin… - Proceedings of the …, 2014 - ui.adsabs.harvard.edu
The safe, selective, and efficient delivery of siRNA is a key challenge to the broad
application of siRNA therapeutics in humans. Motivated by the structure of lipoproteins, we …
application of siRNA therapeutics in humans. Motivated by the structure of lipoproteins, we …
[HTML][HTML] From the Cover: Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Y Dong, KT Love, JR Dorkin… - Proceedings of the …, 2014 - ncbi.nlm.nih.gov
Hepatocytes in Mice. Single amino acids were reacted with aldehydes, acrylates, and
epoxides to produce sets 1–3 (Fig. 2 and SI Appendix, Table S1; 60 compounds) …
epoxides to produce sets 1–3 (Fig. 2 and SI Appendix, Table S1; 60 compounds) …
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Y Dong, KT Love, JR Dorkin… - Proceedings of the …, 2014 - pubmed.ncbi.nlm.nih.gov
siRNA therapeutics have promise for the treatment of a wide range of genetic disorders.
Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA …
Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA …
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Y Dong, KT Love, JR Dorkin… - … of the National …, 2014 - ohiostate.elsevierpure.com
Abstract siRNA therapeutics have promise for the treatment of a wide range of genetic
disorders. Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and …
disorders. Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and …
[PDF][PDF] Lipopeptide Nanoparticles for Potent and Selective siRNA Delivery in Rodents and Nonhuman Primates
Y Dong, KT Love, JR Dorkin, S Sirirungruang… - Proceedings of the … - academia.edu
Edited* by Alexander M. Klibanov, Massachusetts Institute of Technology, Cambridge, MA,
and approved January 16, 2014 (received for review December 10, 2013) siRNA …
and approved January 16, 2014 (received for review December 10, 2013) siRNA …
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Y Dong, KT Love, JR Dorkin, S Sirirungruang… - Proceedings of the …, 2014 - cir.nii.ac.jp
抄録< jats: title> Significance</jats: title>< jats: p> The safe, selective, and efficient delivery of
siRNA is a key challenge to the broad application of siRNA therapeutics in humans …
siRNA is a key challenge to the broad application of siRNA therapeutics in humans …
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Y Dong, KT Love, JR Dorkin, S Sirirungruang, Y Zhang… - 2014 - dspace.mit.edu
siRNA therapeutics have promise for the treatment of a wide range of genetic disorders.
Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA …
Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA …